• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Open . Symptom burden, care pathways and treatment experiences of healthcare workers with post-COVID-19 syndrome (SCOPE-CARE): a mixed-methods s

tetano

Editor, Senior Moderator
BMJ Open


. 2026 Jun 24;16(6):e117666.
doi: 10.1136/bmjopen-2026-117666.
Symptom burden, care pathways and treatment experiences of healthcare workers with post-COVID-19 syndrome (SCOPE-CARE): a mixed-methods study protocol

Mirja Baumgart[SUP] 1 [/SUP], Laura Luedtke[SUP] 2 [/SUP], Jonas Petter[SUP] 2 [/SUP], Levente Kriston[SUP] 2 [/SUP], Albert Nienhaus[SUP] 3 [/SUP], Martin Härter[SUP] 2 [/SUP]


Affiliations
Abstract

Introduction: Healthcare workers (HCWs) have been disproportionately affected by the COVID-19 pandemic, both as carers and as patients. Many individuals developed persistent symptoms following an acute SARS-CoV-2 infection, known as post-COVID-19 syndrome (PCS). Previous research indicates that a significant proportion of HCWs experience long-lasting and debilitating symptoms of PCS. The aim of this study is to investigate the longitudinal symptom burden as well as the care pathways and treatment experiences of PCS-affected HCWs insured by the German Social Accident Insurance Institution for Health and Welfare.
Methods and analysis: The study uses a mixed-methods approach. The longitudinal survey will extend a cohort study of n=2436 HCWs (started in 2023) affected by PCS, adding two measurement points, set in 2025 (T[SUB]3[/SUB]) and 2026 (T[SUB]4[/SUB]). Additionally, interviews on care pathways and treatment experiences will be conducted with a subsample of n=60 PCS-affected HCWs. Another subsample of n=30 HCWs will be asked to participate in ecological momentary assessments of symptom burden, emotional well-being and coping strategies. Analyses of routinely collected data by the insurance company will complement the study data. The study is supported by an advisory board comprising PCS-affected HCWs who assist with the content of both qualitative and quantitative surveys.
Ethics and dissemination: This study was approved by the Local Ethics Committee of the University Medical Center Hamburg-Eppendorf, Germany (LPEK-0909, 1 May 2025; amendment: LPEK-0954, 18 September 2025). The results of the study will be presented at conferences and published in peer-reviewed journals.
Registration details: https://drks.de/search/de/trial/DRKS00035957.

Keywords: Health Services; Health Services Accessibility; Post-Acute COVID-19 Syndrome.

 
Back
Top